Монгол Улсын үндэсний цөм FHIR удирдамж (Mongolian National Core IG) - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: CDC CVX Vaccine Codes - XML Representation

Active as of 2026-09-08

Raw xml | Download

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="mn-cvx"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem mn-cvx</b></p><a name="mn-cvx"> </a><a name="hcmn-cvx"> </a><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class="grid"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td></tr><tr><td>status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>http://hl7.org/fhir/sid/cvx</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>status</b></td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">54<a name="mn-cvx-54"> </a></td><td>adenovirus, type 4</td><td>adenovirus vaccine, type 4, live, oral</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">55<a name="mn-cvx-55"> </a></td><td>adenovirus, type 7</td><td>adenovirus vaccine, type 7, live, oral</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">82<a name="mn-cvx-82"> </a></td><td>adenovirus, unspecified formulation</td><td>adenovirus vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">24<a name="mn-cvx-24"> </a></td><td>Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis</td><td>Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis</td><td/></tr><tr><td style="white-space:nowrap">19<a name="mn-cvx-19"> </a></td><td>BCG</td><td>Bacillus Calmette-Guerin vaccine</td><td/></tr><tr><td style="white-space:nowrap">27<a name="mn-cvx-27"> </a></td><td>botulinum antitoxin</td><td/><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">26<a name="mn-cvx-26"> </a></td><td>cholera, unspecified formulation</td><td>cholera vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">29<a name="mn-cvx-29"> </a></td><td>CMVIG</td><td>cytomegalovirus immune globulin, intravenous</td><td/></tr><tr><td style="white-space:nowrap">56<a name="mn-cvx-56"> </a></td><td>dengue fever tetravalent</td><td>dengue fever vaccine, tetravalent</td><td/></tr><tr><td style="white-space:nowrap">12<a name="mn-cvx-12"> </a></td><td>diphtheria antitoxin</td><td/><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">28<a name="mn-cvx-28"> </a></td><td>DT (pediatric)</td><td>diphtheria and tetanus toxoids, adsorbed for pediatric use</td><td>retired</td></tr><tr><td style="white-space:nowrap">20<a name="mn-cvx-20"> </a></td><td>DTaP</td><td>diphtheria, tetanus toxoids and acellular pertussis vaccine</td><td/></tr><tr><td style="white-space:nowrap">106<a name="mn-cvx-106"> </a></td><td>DTaP, 5 pertussis antigens</td><td>diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">107<a name="mn-cvx-107"> </a></td><td>DTaP, unspecified formulation</td><td>diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">110<a name="mn-cvx-110"> </a></td><td>DTaP-Hep B-IPV</td><td>DTaP-hepatitis B and poliovirus vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">50<a name="mn-cvx-50"> </a></td><td>DTaP-Hib</td><td>DTaP-Haemophilus influenzae type b conjugate vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">120<a name="mn-cvx-120"> </a></td><td>DTaP-Hib-IPV</td><td>diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)</td><td/></tr><tr><td style="white-space:nowrap">130<a name="mn-cvx-130"> </a></td><td>DTaP-IPV</td><td>Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">01<a name="mn-cvx-01"> </a></td><td>DTP</td><td>diphtheria, tetanus toxoids and pertussis vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">22<a name="mn-cvx-22"> </a></td><td>DTP-Hib</td><td>DTP-Haemophilus influenzae type b conjugate vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">102<a name="mn-cvx-102"> </a></td><td>DTP-Hib-Hep B</td><td>DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">57<a name="mn-cvx-57"> </a></td><td>hantavirus</td><td>hantavirus vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">52<a name="mn-cvx-52"> </a></td><td>Hep A, adult</td><td>hepatitis A vaccine, adult dosage</td><td/></tr><tr><td style="white-space:nowrap">83<a name="mn-cvx-83"> </a></td><td>Hep A, ped/adol, 2 dose</td><td>hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">84<a name="mn-cvx-84"> </a></td><td>Hep A, ped/adol, 3 dose</td><td>hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">31<a name="mn-cvx-31"> </a></td><td>Hep A, pediatric, unspecified formulation</td><td>hepatitis A vaccine, pediatric dosage, unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">85<a name="mn-cvx-85"> </a></td><td>Hep A, unspecified formulation</td><td>hepatitis A vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">104<a name="mn-cvx-104"> </a></td><td>Hep A-Hep B</td><td>hepatitis A and hepatitis B vaccine</td><td/></tr><tr><td style="white-space:nowrap">30<a name="mn-cvx-30"> </a></td><td>HBIG</td><td>hepatitis B immune globulin</td><td/></tr><tr><td style="white-space:nowrap">08<a name="mn-cvx-08"> </a></td><td>Hep B, adolescent or pediatric</td><td>hepatitis B vaccine, pediatric or pediatric/adolescent dosage</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">42<a name="mn-cvx-42"> </a></td><td>Hep B, adolescent/high risk infant</td><td>hepatitis B vaccine, adolescent/high risk infant dosage</td><td>retired</td></tr><tr><td style="white-space:nowrap">43<a name="mn-cvx-43"> </a></td><td>Hep B, adult</td><td>hepatitis B vaccine, adult dosage</td><td/></tr><tr><td style="white-space:nowrap">44<a name="mn-cvx-44"> </a></td><td>Hep B, high-dosage, dialysis or IC</td><td>Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">45<a name="mn-cvx-45"> </a></td><td>Hep B, unspecified formulation</td><td>hepatitis B vaccine, unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">58<a name="mn-cvx-58"> </a></td><td>Hep C</td><td>hepatitis C vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">59<a name="mn-cvx-59"> </a></td><td>Hep E</td><td>hepatitis E vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">60<a name="mn-cvx-60"> </a></td><td>herpes simplex 2</td><td>herpes simplex virus, type 2 vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">46<a name="mn-cvx-46"> </a></td><td>Hib (PRP-D)</td><td>Haemophilus influenzae type b vaccine, PRP-D conjugate</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">47<a name="mn-cvx-47"> </a></td><td>Hib (HbOC)</td><td>Haemophilus influenzae type b vaccine, HbOC conjugate</td><td>retired</td></tr><tr><td style="white-space:nowrap">48<a name="mn-cvx-48"> </a></td><td>Hib (PRP-T)</td><td>Haemophilus influenzae type b vaccine, PRP-T conjugate</td><td/></tr><tr><td style="white-space:nowrap">49<a name="mn-cvx-49"> </a></td><td>Hib (PRP-OMP)</td><td>Haemophilus influenzae type b vaccine, PRP-OMP conjugate</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">17<a name="mn-cvx-17"> </a></td><td>Hib, unspecified formulation</td><td>Haemophilus influenzae type b vaccine, conjugate unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">51<a name="mn-cvx-51"> </a></td><td>Hib-Hep B</td><td>Haemophilus influenzae type b conjugate and Hepatitis B vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">61<a name="mn-cvx-61"> </a></td><td>HIV</td><td>human immunodeficiency virus vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">118<a name="mn-cvx-118"> </a></td><td>HPV, bivalent</td><td>human papilloma virus vaccine, bivalent</td><td>retired</td></tr><tr><td style="white-space:nowrap">62<a name="mn-cvx-62"> </a></td><td>HPV, quadrivalent</td><td>human papilloma virus vaccine, quadrivalent</td><td/></tr><tr><td style="white-space:nowrap">86<a name="mn-cvx-86"> </a></td><td>IG</td><td>immune globulin, intramuscular</td><td/></tr><tr><td style="white-space:nowrap">87<a name="mn-cvx-87"> </a></td><td>IGIV</td><td>immune globulin, intravenous</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">14<a name="mn-cvx-14"> </a></td><td>IG, unspecified formulation</td><td>immune globulin, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">111<a name="mn-cvx-111"> </a></td><td>Influenza, live, trivalent, intranasal, PF</td><td>Influenza, live, trivalent, intranasal, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">15<a name="mn-cvx-15"> </a></td><td>influenza, split (incl. purified surface antigen)</td><td>influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">16<a name="mn-cvx-16"> </a></td><td>influenza, whole</td><td>influenza virus vaccine, whole virus</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">88<a name="mn-cvx-88"> </a></td><td>influenza, unspecified formulation</td><td>influenza virus vaccine, unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">123<a name="mn-cvx-123"> </a></td><td>influenza, H5N1-1203</td><td>influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)</td><td>retired</td></tr><tr><td style="white-space:nowrap">10<a name="mn-cvx-10"> </a></td><td>IPV</td><td>poliovirus vaccine, inactivated</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">02<a name="mn-cvx-02"> </a></td><td>OPV, trivalent</td><td>trivalent poliovirus vaccine, live, oral</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">89<a name="mn-cvx-89"> </a></td><td>polio, unspecified formulation</td><td>poliovirus vaccine, unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">39<a name="mn-cvx-39"> </a></td><td>Japanese encephalitis SC</td><td>Japanese Encephalitis Vaccine SC</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">63<a name="mn-cvx-63"> </a></td><td>Junin virus</td><td>Junin virus vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">64<a name="mn-cvx-64"> </a></td><td>leishmaniasis</td><td>leishmaniasis vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">65<a name="mn-cvx-65"> </a></td><td>leprosy</td><td>leprosy vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">66<a name="mn-cvx-66"> </a></td><td>Lyme disease</td><td>Lyme disease vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">03<a name="mn-cvx-03"> </a></td><td>MMR</td><td>measles, mumps and rubella virus vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">04<a name="mn-cvx-04"> </a></td><td>M/R</td><td>measles and rubella virus vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">94<a name="mn-cvx-94"> </a></td><td>MMRV</td><td>measles, mumps, rubella, and varicella virus vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">67<a name="mn-cvx-67"> </a></td><td>malaria</td><td>malaria vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">05<a name="mn-cvx-05"> </a></td><td>measles</td><td>measles virus vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">68<a name="mn-cvx-68"> </a></td><td>melanoma</td><td>melanoma vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">32<a name="mn-cvx-32"> </a></td><td>meningococcal MPSV4</td><td>meningococcal polysaccharide vaccine (MPSV4)</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">103<a name="mn-cvx-103"> </a></td><td>meningococcal C conjugate</td><td>meningococcal C conjugate vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">114<a name="mn-cvx-114"> </a></td><td>meningococcal MCV4P</td><td>meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">108<a name="mn-cvx-108"> </a></td><td>meningococcal ACWY, unspecified formulation</td><td>meningococcal ACWY vaccine, unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">07<a name="mn-cvx-07"> </a></td><td>mumps</td><td>mumps virus vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">69<a name="mn-cvx-69"> </a></td><td>parainfluenza-3</td><td>parainfluenza-3 virus vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">11<a name="mn-cvx-11"> </a></td><td>pertussis</td><td>pertussis vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">23<a name="mn-cvx-23"> </a></td><td>plague</td><td>plague vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">33<a name="mn-cvx-33"> </a></td><td>pneumococcal polysaccharide PPV23</td><td>pneumococcal polysaccharide vaccine, 23 valent</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">100<a name="mn-cvx-100"> </a></td><td>pneumococcal conjugate PCV 7</td><td>pneumococcal conjugate vaccine, 7 valent</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">109<a name="mn-cvx-109"> </a></td><td>pneumococcal, unspecified formulation</td><td>pneumococcal vaccine, unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">70<a name="mn-cvx-70"> </a></td><td>Q fever</td><td>Q fever vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">18<a name="mn-cvx-18"> </a></td><td>rabies, intramuscular injection</td><td>rabies vaccine, for intramuscular injection RETIRED CODE</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">40<a name="mn-cvx-40"> </a></td><td>rabies, intradermal injection</td><td>rabies vaccine, for intradermal injection</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">90<a name="mn-cvx-90"> </a></td><td>rabies, unspecified formulation</td><td>rabies vaccine, unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">72<a name="mn-cvx-72"> </a></td><td>rheumatic fever</td><td>rheumatic fever vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">73<a name="mn-cvx-73"> </a></td><td>Rift Valley fever</td><td>Rift Valley fever vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">34<a name="mn-cvx-34"> </a></td><td>RIG</td><td>rabies immune globulin</td><td/></tr><tr><td style="white-space:nowrap">119<a name="mn-cvx-119"> </a></td><td>rotavirus, monovalent</td><td>rotavirus, live, monovalent vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">122<a name="mn-cvx-122"> </a></td><td>rotavirus, unspecified formulation</td><td>rotavirus vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">116<a name="mn-cvx-116"> </a></td><td>rotavirus, pentavalent</td><td>rotavirus, live, pentavalent vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">74<a name="mn-cvx-74"> </a></td><td>rotavirus, tetravalent</td><td>rotavirus, live, tetravalent vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">71<a name="mn-cvx-71"> </a></td><td>RSV-IGIV</td><td>respiratory syncytial virus immune globulin, intravenous</td><td>retired</td></tr><tr><td style="white-space:nowrap">93<a name="mn-cvx-93"> </a></td><td>RSV-MAb</td><td>respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">06<a name="mn-cvx-06"> </a></td><td>rubella</td><td>rubella virus vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">38<a name="mn-cvx-38"> </a></td><td>rubella/mumps</td><td>rubella and mumps virus vaccine</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">76<a name="mn-cvx-76"> </a></td><td>Staphylococcus bacterio lysate</td><td>Staphylococcus bacteriophage lysate</td><td>retired</td></tr><tr><td style="white-space:nowrap">113<a name="mn-cvx-113"> </a></td><td>Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed</td><td>tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)</td><td/></tr><tr><td style="white-space:nowrap">09<a name="mn-cvx-09"> </a></td><td>Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed</td><td>tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)</td><td/></tr><tr><td style="white-space:nowrap">115<a name="mn-cvx-115"> </a></td><td>Tdap</td><td>tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">35<a name="mn-cvx-35"> </a></td><td>tetanus toxoid, adsorbed</td><td/><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">112<a name="mn-cvx-112"> </a></td><td>tetanus toxoid, unspecified formulation</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">77<a name="mn-cvx-77"> </a></td><td>Tick-borne encephalitis vaccine (non-US)</td><td/><td/></tr><tr><td style="white-space:nowrap">13<a name="mn-cvx-13"> </a></td><td>TIG</td><td>tetanus immune globulin</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">95<a name="mn-cvx-95"> </a></td><td>TST-OT tine test</td><td>tuberculin skin test; old tuberculin, multipuncture device</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">96<a name="mn-cvx-96"> </a></td><td>TST-PPD intradermal</td><td>tuberculin skin test; purified protein derivative solution, intradermal</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">97<a name="mn-cvx-97"> </a></td><td>TST-PPD tine test</td><td>tuberculin skin test; purified protein derivative, multipuncture device</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">98<a name="mn-cvx-98"> </a></td><td>TST, unspecified formulation</td><td>tuberculin skin test; unspecified formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">78<a name="mn-cvx-78"> </a></td><td>tularemia vaccine</td><td/><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">91<a name="mn-cvx-91"> </a></td><td>typhoid, unspecified formulation</td><td>typhoid vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">25<a name="mn-cvx-25"> </a></td><td>typhoid, oral</td><td>typhoid vaccine, live, oral</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">41<a name="mn-cvx-41"> </a></td><td>typhoid, parenteral</td><td>typhoid vaccine, parenteral, other than acetone-killed, dried</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">53<a name="mn-cvx-53"> </a></td><td>typhoid, parenteral, AKD (U.S. military)</td><td>typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</td><td>retired</td></tr><tr><td style="white-space:nowrap">101<a name="mn-cvx-101"> </a></td><td>typhoid, ViCPs</td><td>typhoid Vi capsular polysaccharide vaccine</td><td/></tr><tr><td style="white-space:nowrap">75<a name="mn-cvx-75"> </a></td><td>Vaccinia (smallpox, monkeypox), live</td><td>Vaccinia (smallpox, monkeypox) vaccine, live</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">105<a name="mn-cvx-105"> </a></td><td>vaccinia (smallpox) diluted</td><td>vaccinia (smallpox) vaccine, diluted</td><td>retired</td></tr><tr><td style="white-space:nowrap">79<a name="mn-cvx-79"> </a></td><td>vaccinia immune globulin</td><td/><td/></tr><tr><td style="white-space:nowrap">21<a name="mn-cvx-21"> </a></td><td>varicella</td><td>varicella virus vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">81<a name="mn-cvx-81"> </a></td><td>VEE, inactivated</td><td>Venezuelan equine encephalitis, inactivated</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">80<a name="mn-cvx-80"> </a></td><td>VEE, live</td><td>Venezuelan equine encephalitis, live, attenuated</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">92<a name="mn-cvx-92"> </a></td><td>VEE, unspecified formulation</td><td>Venezuelan equine encephalitis vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">36<a name="mn-cvx-36"> </a></td><td>VZIG</td><td>varicella zoster immune globulin</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">117<a name="mn-cvx-117"> </a></td><td>VZIG (IND)</td><td>varicella zoster immune globulin (Investigational New Drug)</td><td>retired</td></tr><tr><td style="white-space:nowrap">37<a name="mn-cvx-37"> </a></td><td>yellow fever live</td><td>yellow fever vaccine live</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">121<a name="mn-cvx-121"> </a></td><td>zoster live</td><td>zoster vaccine, live</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">998<a name="mn-cvx-998"> </a></td><td>no vaccine administered</td><td/><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">999<a name="mn-cvx-999"> </a></td><td>unknown</td><td>unknown vaccine or immune globulin</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">99<a name="mn-cvx-99"> </a></td><td>RESERVED - do not use</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">133<a name="mn-cvx-133"> </a></td><td>Pneumococcal conjugate PCV 13</td><td>pneumococcal conjugate vaccine, 13 valent</td><td/></tr><tr><td style="white-space:nowrap">134<a name="mn-cvx-134"> </a></td><td>Japanese Encephalitis IM</td><td>Japanese Encephalitis vaccine for intramuscular administration</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">137<a name="mn-cvx-137"> </a></td><td>HPV, unspecified formulation</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">136<a name="mn-cvx-136"> </a></td><td>Meningococcal MCV4O</td><td>meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)</td><td/></tr><tr><td style="white-space:nowrap">135<a name="mn-cvx-135"> </a></td><td>Influenza, high-dose, trivalent, PF</td><td>Influenza, high-dose, split virus, trivalent, injectable, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">131<a name="mn-cvx-131"> </a></td><td>typhus, historical</td><td>Historical record of a typhus vaccination</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">132<a name="mn-cvx-132"> </a></td><td>DTaP-IPV-HIB-HEP B, historical</td><td>Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">128<a name="mn-cvx-128"> </a></td><td>Novel Influenza-H1N1-09, all formulations</td><td>Novel influenza-H1N1-09, all formulations</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">125<a name="mn-cvx-125"> </a></td><td>Novel Influenza-H1N1-09, nasal</td><td>Novel Influenza-H1N1-09, live virus for nasal administration</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">126<a name="mn-cvx-126"> </a></td><td>Novel influenza-H1N1-09, preservative-free</td><td>Novel influenza-H1N1-09, preservative-free, injectable</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">127<a name="mn-cvx-127"> </a></td><td>Novel influenza-H1N1-09</td><td>Novel influenza-H1N1-09, injectable</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">138<a name="mn-cvx-138"> </a></td><td>Td (adult)</td><td>tetanus and diphtheria toxoids, not adsorbed, for adult use</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">139<a name="mn-cvx-139"> </a></td><td>Td(adult) unspecified formulation</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">140<a name="mn-cvx-140"> </a></td><td>Influenza, split virus, trivalent, PF</td><td>Influenza, split virus, trivalent, injectable, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">129<a name="mn-cvx-129"> </a></td><td>Japanese Encephalitis, unspecified formulation</td><td>Japanese Encephalitis vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">141<a name="mn-cvx-141"> </a></td><td>Influenza, split virus, trivalent, preservative</td><td>Influenza, split virus, trivalent, injectable, contains preservative</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">142<a name="mn-cvx-142"> </a></td><td>tetanus toxoid, not adsorbed</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">143<a name="mn-cvx-143"> </a></td><td>Adenovirus types 4 and 7</td><td>Adenovirus, type 4 and type 7, live, oral</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">144<a name="mn-cvx-144"> </a></td><td>influenza, seasonal, intradermal, preservative free</td><td>seasonal influenza, intradermal, preservative free</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">145<a name="mn-cvx-145"> </a></td><td>RSV-MAb (new)</td><td>respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular</td><td>retired</td></tr><tr><td style="white-space:nowrap">146<a name="mn-cvx-146"> </a></td><td>DTaP,IPV,Hib,HepB</td><td>Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">147<a name="mn-cvx-147"> </a></td><td>meningococcal MCV4, unspecified formulation</td><td>Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">148<a name="mn-cvx-148"> </a></td><td>Meningococcal C/Y-HIB PRP</td><td>Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine</td><td>retired</td></tr><tr><td style="white-space:nowrap">149<a name="mn-cvx-149"> </a></td><td>Influenza, live, quadrivalent, intranasal</td><td/><td/></tr><tr><td style="white-space:nowrap">150<a name="mn-cvx-150"> </a></td><td>Influenza, split virus, quadrivalent, PF</td><td>Influenza, split virus, quadrivalent, injectable, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">151<a name="mn-cvx-151"> </a></td><td>influenza nasal, unspecified formulation</td><td/><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">152<a name="mn-cvx-152"> </a></td><td>Pneumococcal Conjugate, unspecified formulation</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">153<a name="mn-cvx-153"> </a></td><td>Influenza, MDCK, trivalent, PF</td><td>Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">154<a name="mn-cvx-154"> </a></td><td>Hep A, IG</td><td>Hepatitis A immune globulin</td><td>retired</td></tr><tr><td style="white-space:nowrap">155<a name="mn-cvx-155"> </a></td><td>Influenza, recombinant, trivalent, PF</td><td>Influenza, recombinant, trivalent, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">156<a name="mn-cvx-156"> </a></td><td>Rho(D)-IG</td><td>Rho(D) Immune globulin- IV or IM</td><td/></tr><tr><td style="white-space:nowrap">157<a name="mn-cvx-157"> </a></td><td>Rho(D) -IG IM</td><td>Rho(D) Immune globulin - IM</td><td/></tr><tr><td style="white-space:nowrap">158<a name="mn-cvx-158"> </a></td><td>Influenza, split virus, quadrivalent, preservative</td><td>Influenza, split virus, quadrivalent, injectable, contains preservative</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">159<a name="mn-cvx-159"> </a></td><td>Rho(D) - Unspecified formulation</td><td>Rho(D) Unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">160<a name="mn-cvx-160"> </a></td><td>Influenza A monovalent (H5N1), ADJUVANTED-2013</td><td>Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013</td><td/></tr><tr><td style="white-space:nowrap">801<a name="mn-cvx-801"> </a></td><td>AS03 Adjuvant</td><td/><td/></tr><tr><td style="white-space:nowrap">161<a name="mn-cvx-161"> </a></td><td>Influenza, injectable,quadrivalent, preservative free, pediatric</td><td/><td/></tr><tr><td style="white-space:nowrap">162<a name="mn-cvx-162"> </a></td><td>meningococcal B, recombinant</td><td>meningococcal B vaccine, fully recombinant</td><td/></tr><tr><td style="white-space:nowrap">163<a name="mn-cvx-163"> </a></td><td>meningococcal B, OMV</td><td>meningococcal B vaccine, recombinant, OMV, adjuvanted</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">164<a name="mn-cvx-164"> </a></td><td>meningococcal B, unspecified</td><td>meningococcal B, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">165<a name="mn-cvx-165"> </a></td><td>HPV9</td><td>Human Papillomavirus 9-valent vaccine</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">166<a name="mn-cvx-166"> </a></td><td>influenza, intradermal, quadrivalent, preservative free</td><td>influenza, intradermal, quadrivalent, preservative free, injectable</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">167<a name="mn-cvx-167"> </a></td><td>meningococcal, unknown serogroups</td><td>meningococcal vaccine of unknown formulation and unknown serogroups</td><td>retired</td></tr><tr><td style="white-space:nowrap">168<a name="mn-cvx-168"> </a></td><td>Influenza, adjuvanted, trivalent, PF</td><td>Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">169<a name="mn-cvx-169"> </a></td><td>Hep A, live attenuated</td><td>Hep A, live attenuated-IM</td><td/></tr><tr><td style="white-space:nowrap">170<a name="mn-cvx-170"> </a></td><td>DTAP/IPV/HIB - non-US</td><td>non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)</td><td/></tr><tr><td style="white-space:nowrap">171<a name="mn-cvx-171"> </a></td><td>Influenza, MDCK, quadrivalent, PF</td><td>Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">172<a name="mn-cvx-172"> </a></td><td>cholera, WC-rBS</td><td/><td/></tr><tr><td style="white-space:nowrap">173<a name="mn-cvx-173"> </a></td><td>cholera, BivWC</td><td/><td/></tr><tr><td style="white-space:nowrap">174<a name="mn-cvx-174"> </a></td><td>cholera, live attenuated</td><td/><td/></tr><tr><td style="white-space:nowrap">175<a name="mn-cvx-175"> </a></td><td>Rabies - IM Diploid cell culture</td><td>Human Rabies vaccine from human diploid cell culture</td><td/></tr><tr><td style="white-space:nowrap">176<a name="mn-cvx-176"> </a></td><td>Rabies - IM fibroblast culture</td><td>Human rabies vaccine from Chicken fibroblast culture</td><td/></tr><tr><td style="white-space:nowrap">177<a name="mn-cvx-177"> </a></td><td>PCV10</td><td>pneumococcal conjugate vaccine, 10 valent</td><td/></tr><tr><td style="white-space:nowrap">178<a name="mn-cvx-178"> </a></td><td>OPV bivalent</td><td>Non-US bivalent oral polio vaccine (types 1 and 3)</td><td/></tr><tr><td style="white-space:nowrap">179<a name="mn-cvx-179"> </a></td><td>OPV ,monovalent, unspecified</td><td>Non-US monovalent oral polio vaccine, unspecified formulation</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">180<a name="mn-cvx-180"> </a></td><td>tetanus immune globulin</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">181<a name="mn-cvx-181"> </a></td><td>anthrax immune globulin</td><td/><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">182<a name="mn-cvx-182"> </a></td><td>OPV, Unspecified</td><td>Oral Polio Vaccine, Unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">183<a name="mn-cvx-183"> </a></td><td>Yellow fever vaccine live - alt</td><td>Yellow fever vaccine live - alternative formulation for vaccine shortage</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">184<a name="mn-cvx-184"> </a></td><td>Yellow fever, unspecified</td><td>Yellow fever vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">185<a name="mn-cvx-185"> </a></td><td>Influenza, recombinant, quadrivalent, PF</td><td>Influenza, recombinant, quadrivalent, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">186<a name="mn-cvx-186"> </a></td><td>Influenza, MDCK, quadrivalent, preservative</td><td>Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative</td><td/></tr><tr><td style="white-space:nowrap">187<a name="mn-cvx-187"> </a></td><td>zoster recombinant</td><td>zoster vaccine recombinant</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">188<a name="mn-cvx-188"> </a></td><td>zoster, unspecified formulation</td><td>zoster vaccine, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">189<a name="mn-cvx-189"> </a></td><td>HepB-CpG</td><td>Hepatitis B vaccine (recombinant), CpG adjuvanted</td><td/></tr><tr><td style="white-space:nowrap">190<a name="mn-cvx-190"> </a></td><td>Typhoid conjugate vaccine (TCV)</td><td>Typhoid conjugate vaccine (non-US)</td><td/></tr><tr><td style="white-space:nowrap">191<a name="mn-cvx-191"> </a></td><td>meningococcal A polysaccharide (non-US)</td><td>meningococcal A polysaccharide vaccine (non-US)</td><td/></tr><tr><td style="white-space:nowrap">192<a name="mn-cvx-192"> </a></td><td>meningococcal AC polysaccharide (non-US)</td><td>meningococcal AC polysaccharide vaccine (non-US)</td><td/></tr><tr><td style="white-space:nowrap">193<a name="mn-cvx-193"> </a></td><td>Hep A-Hep B, pediatric/adolescent</td><td>hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">194<a name="mn-cvx-194"> </a></td><td>Influenza, Southern Hemisphere</td><td>influenza, Southern Hemisphere, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">195<a name="mn-cvx-195"> </a></td><td>DT, IPV adsorbed</td><td>Diphtheria, Tetanus, Poliomyelitis adsorbed</td><td/></tr><tr><td style="white-space:nowrap">196<a name="mn-cvx-196"> </a></td><td>Td, adsorbed, preservative free, adult use, Lf unspecified</td><td>tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified</td><td/></tr><tr><td style="white-space:nowrap">197<a name="mn-cvx-197"> </a></td><td>Influenza, high-dose, quadrivalent, PF</td><td>Influenza, high-dose, split virus, quadrivalent, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">200<a name="mn-cvx-200"> </a></td><td>influenza, Southern Hemisphere, pediatric, preservative free</td><td>influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free</td><td/></tr><tr><td style="white-space:nowrap">201<a name="mn-cvx-201"> </a></td><td>Influenza, Southern Hemisphere, quadrivalent, PF</td><td>Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free</td><td/></tr><tr><td style="white-space:nowrap">202<a name="mn-cvx-202"> </a></td><td>influenza, Southern Hemisphere, quadrivalent, with preservative</td><td>influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative</td><td/></tr><tr><td style="white-space:nowrap">198<a name="mn-cvx-198"> </a></td><td>DTP-hepB-Hib Pentavalent Non-US</td><td>Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)</td><td/></tr><tr><td style="white-space:nowrap">203<a name="mn-cvx-203"> </a></td><td>meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)</td><td>meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free</td><td/></tr><tr><td style="white-space:nowrap">205<a name="mn-cvx-205"> </a></td><td>Influenza, adjuvanted, quadrivalent, PF</td><td>Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">206<a name="mn-cvx-206"> </a></td><td>Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection</td><td>Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">207<a name="mn-cvx-207"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">208<a name="mn-cvx-208"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">213<a name="mn-cvx-213"> </a></td><td>SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">210<a name="mn-cvx-210"> </a></td><td>COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL</td><td>SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">212<a name="mn-cvx-212"> </a></td><td>COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL</td><td>SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL</td><td>retired</td></tr><tr><td style="white-space:nowrap">204<a name="mn-cvx-204"> </a></td><td>Ebola Zaire vaccine, live, recombinant, 1mL dose</td><td/><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">214<a name="mn-cvx-214"> </a></td><td>Ebola, unspecified</td><td/><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">211<a name="mn-cvx-211"> </a></td><td>COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL</td><td>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose</td><td>retired</td></tr><tr><td style="white-space:nowrap">500<a name="mn-cvx-500"> </a></td><td>COVID-19 Non-US Vaccine, UNSPECIFIED</td><td>SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED</td><td/></tr><tr><td style="white-space:nowrap">501<a name="mn-cvx-501"> </a></td><td>COVID-19 IV Non-US Vaccine (QAZCOVID-IN)</td><td>SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)</td><td/></tr><tr><td style="white-space:nowrap">502<a name="mn-cvx-502"> </a></td><td>COVID-19 IV Non-US Vaccine (COVAXIN)</td><td>SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)</td><td/></tr><tr><td style="white-space:nowrap">503<a name="mn-cvx-503"> </a></td><td>COVID-19 LAV Non-US Vaccine (COVIVAC)</td><td>SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)</td><td/></tr><tr><td style="white-space:nowrap">504<a name="mn-cvx-504"> </a></td><td>COVID-19 VVnr Non-US Vaccine (Sputnik Light)</td><td>SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)</td><td/></tr><tr><td style="white-space:nowrap">505<a name="mn-cvx-505"> </a></td><td>COVID-19 VVnr Non-US Vaccine (Sputnik V)</td><td>SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)</td><td/></tr><tr><td style="white-space:nowrap">506<a name="mn-cvx-506"> </a></td><td>COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology</td><td>SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology</td><td/></tr><tr><td style="white-space:nowrap">507<a name="mn-cvx-507"> </a></td><td>COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)</td><td>SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)</td><td/></tr><tr><td style="white-space:nowrap">508<a name="mn-cvx-508"> </a></td><td>COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)</td><td>SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)</td><td/></tr><tr><td style="white-space:nowrap">509<a name="mn-cvx-509"> </a></td><td>COVID-19 PS Non-US Vaccine (EpiVacCorona)</td><td>SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)</td><td/></tr><tr><td style="white-space:nowrap">510<a name="mn-cvx-510"> </a></td><td>COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)</td><td>SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)</td><td/></tr><tr><td style="white-space:nowrap">511<a name="mn-cvx-511"> </a></td><td>COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)</td><td>SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)</td><td/></tr><tr><td style="white-space:nowrap">215<a name="mn-cvx-215"> </a></td><td>Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF</td><td>Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free</td><td/></tr><tr><td style="white-space:nowrap">216<a name="mn-cvx-216"> </a></td><td>Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF</td><td>Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">219<a name="mn-cvx-219"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">217<a name="mn-cvx-217"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">218<a name="mn-cvx-218"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">220<a name="mn-cvx-220"> </a></td><td>HepB recombinant, 3-antigen, Al(OH)3</td><td>Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">221<a name="mn-cvx-221"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">222<a name="mn-cvx-222"> </a></td><td>Tick-borne encephalitis, unspecified</td><td>Tick-borne encephalitis vaccine, unspecified</td><td>retired</td></tr><tr><td style="white-space:nowrap">223<a name="mn-cvx-223"> </a></td><td>Tick-borne encephalitis, inactivated, PF, 0.25mL</td><td>Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose</td><td/></tr><tr><td style="white-space:nowrap">224<a name="mn-cvx-224"> </a></td><td>Tick-borne encephalitis, inactivated, PF, 0.5mL</td><td>Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">225<a name="mn-cvx-225"> </a></td><td>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL</td><td>SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">226<a name="mn-cvx-226"> </a></td><td>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL</td><td>SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose</td><td>retired</td></tr><tr><td style="white-space:nowrap">512<a name="mn-cvx-512"> </a></td><td>SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)</td><td>SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)</td><td/></tr><tr><td style="white-space:nowrap">513<a name="mn-cvx-513"> </a></td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)</td><td>SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)</td><td/></tr><tr><td style="white-space:nowrap">514<a name="mn-cvx-514"> </a></td><td>SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)</td><td>SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)</td><td/></tr><tr><td style="white-space:nowrap">515<a name="mn-cvx-515"> </a></td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)</td><td>SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)</td><td/></tr><tr><td style="white-space:nowrap">516<a name="mn-cvx-516"> </a></td><td>COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)</td><td>SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)</td><td/></tr><tr><td style="white-space:nowrap">517<a name="mn-cvx-517"> </a></td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)</td><td>SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">227<a name="mn-cvx-227"> </a></td><td>COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">228<a name="mn-cvx-228"> </a></td><td>COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">229<a name="mn-cvx-229"> </a></td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">301<a name="mn-cvx-301"> </a></td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">300<a name="mn-cvx-300"> </a></td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">230<a name="mn-cvx-230"> </a></td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose</td><td>retired</td></tr><tr><td style="white-space:nowrap">518<a name="mn-cvx-518"> </a></td><td>COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)</td><td>SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)</td><td/></tr><tr><td style="white-space:nowrap">519<a name="mn-cvx-519"> </a></td><td>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna</td><td>SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna</td><td/></tr><tr><td style="white-space:nowrap">520<a name="mn-cvx-520"> </a></td><td>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech</td><td>SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech</td><td/></tr><tr><td style="white-space:nowrap">521<a name="mn-cvx-521"> </a></td><td>COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK</td><td>SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK</td><td/></tr><tr><td style="white-space:nowrap">231<a name="mn-cvx-231"> </a></td><td>influenza, Southern Hemisphere, high-dose, quadrivalent</td><td>influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free</td><td/></tr><tr><td style="white-space:nowrap">303<a name="mn-cvx-303"> </a></td><td>RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF</td><td>Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">304<a name="mn-cvx-304"> </a></td><td>Respiratory syncytial virus (RSV), unspecified</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">305<a name="mn-cvx-305"> </a></td><td>RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF</td><td>Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free</td><td/></tr><tr><td style="white-space:nowrap">306<a name="mn-cvx-306"> </a></td><td>RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months</td><td>Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months</td><td/></tr><tr><td style="white-space:nowrap">307<a name="mn-cvx-307"> </a></td><td>RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months</td><td>Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months</td><td/></tr><tr><td style="white-space:nowrap">313<a name="mn-cvx-313"> </a></td><td>COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL</td><td>SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">308<a name="mn-cvx-308"> </a></td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose</td><td>retired</td></tr><tr><td style="white-space:nowrap">309<a name="mn-cvx-309"> </a></td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose</td><td/></tr><tr><td style="white-space:nowrap">310<a name="mn-cvx-310"> </a></td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose</td><td/></tr><tr><td style="white-space:nowrap">312<a name="mn-cvx-312"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose</td><td/></tr><tr><td style="white-space:nowrap">311<a name="mn-cvx-311"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">315<a name="mn-cvx-315"> </a></td><td>Respiratory syncytial virus (RSV) MAB, unspecified</td><td>Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified</td><td>retired</td></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">314<a name="mn-cvx-314"> </a></td><td>Respiratory syncytial virus (RSV) vaccine, unspecified</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">316<a name="mn-cvx-316"> </a></td><td>Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</td><td>Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free</td><td/></tr><tr><td style="white-space:nowrap">317<a name="mn-cvx-317"> </a></td><td>Chikungunya live attenuated vaccine, 0.5 mL, PF</td><td>Chikungunya, live attenuated vaccine, 0.5 mL, preservative free</td><td/></tr><tr><td style="white-space:nowrap">318<a name="mn-cvx-318"> </a></td><td>Anthrax, post-exposure prophylaxis</td><td>Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">319<a name="mn-cvx-319"> </a></td><td>Anthrax vaccine, unspecified</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">320<a name="mn-cvx-320"> </a></td><td>Influenza, MDCK, trivalent, preservative</td><td>Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative</td><td/></tr><tr><td style="white-space:nowrap">321<a name="mn-cvx-321"> </a></td><td>Influenza-avian, H5N8, monovalent, PF</td><td>Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">322<a name="mn-cvx-322"> </a></td><td>Influenza-avian, H5N8, monovalent, preservative</td><td>Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative</td><td/></tr><tr><td style="white-space:nowrap">324<a name="mn-cvx-324"> </a></td><td>Poliovirus, inactivated, fractional-dose (fIPV)</td><td/><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">323<a name="mn-cvx-323"> </a></td><td>Influenza-avian, H5, unspecified formulation</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">326<a name="mn-cvx-326"> </a></td><td>RSV, mRNA, injectable, PF</td><td>Respiratory syncytial virus (RSV), mRNA, injectable, preservative free</td><td/></tr><tr><td style="white-space:nowrap">327<a name="mn-cvx-327"> </a></td><td>Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF</td><td>Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free</td><td/></tr><tr><td style="white-space:nowrap">328<a name="mn-cvx-328"> </a></td><td>Meningococcal oligosaccharide (MenACWY), (MenB), PF</td><td>Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free</td><td/></tr><tr><td style="white-space:nowrap">329<a name="mn-cvx-329"> </a></td><td>Chikungunya, VLP, recombinant, 0.8 mL, PF</td><td>Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">330<a name="mn-cvx-330"> </a></td><td>Dengue fever, unspecified</td><td>Dengue fever, unspecified formulation</td><td>retired</td></tr><tr><td style="white-space:nowrap">331<a name="mn-cvx-331"> </a></td><td>Influenza, Southern Hemisphere, trivalent, PF</td><td>Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">325<a name="mn-cvx-325"> </a></td><td>Vaccinia (smallpox, monkeypox), unspecified</td><td/><td>retired</td></tr><tr><td style="white-space:nowrap">332<a name="mn-cvx-332"> </a></td><td>RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF</td><td>Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free</td><td/></tr><tr><td style="white-space:nowrap">333<a name="mn-cvx-333"> </a></td><td>Influenza, live, trivalent, intranasal, self/caregiver admin, PF</td><td>Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free</td><td/></tr><tr><td style="white-space:nowrap">334<a name="mn-cvx-334"> </a></td><td>COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose</td><td/></tr><tr><td style="white-space:nowrap">337<a name="mn-cvx-337"> </a></td><td>Influenza, Southern Hemisphere, high-dose, trivalent, PF</td><td>Influenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free</td><td/></tr><tr style="background-color: #ffeeee"><td style="white-space:nowrap">302<a name="mn-cvx-302"> </a></td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose</td><td>SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation</td><td>retired</td></tr></table></div>
  </text>
  <url value="http://hl7.org/fhir/sid/cvx"/>
  <version value="0.1.0"/>
  <name value="CVXCodeSystem"/>
  <title value="CDC CVX Vaccine Codes"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2026-09-08T10:09:36+08:00"/>
  <publisher
             value="Эрүүл мэндийн хөгжлийн төв (Health Development Center, Mongolia)"/>
  <contact>
    <name
          value="Эрүүл мэндийн хөгжлийн төв (Health Development Center, Mongolia)"/>
    <telecom>
      <system value="url"/>
      <value value="https://hdc.gov.mn"/>
    </telecom>
  </contact>
  <contact>
    <name value="Эрүүл мэндийн хөгжлийн төв (Health Development Center)"/>
    <telecom>
      <system value="url"/>
      <value value="https://hdc.gov.mn"/>
    </telecom>
  </contact>
  <description
               value="CDC CVX кодын жагсаалт. Дархлаажуулалтын вакциныг кодлоход ашиглана. Эх сурвалж: CDC (https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx)"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="MN"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="289"/>
  <property>
    <code value="status"/>
    <uri value="http://hl7.org/fhir/concept-properties#status"/>
    <type value="code"/>
  </property>
  <concept>
    <code value="54"/>
    <display value="adenovirus, type 4"/>
    <definition value="adenovirus vaccine, type 4, live, oral"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="55"/>
    <display value="adenovirus, type 7"/>
    <definition value="adenovirus vaccine, type 7, live, oral"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="82"/>
    <display value="adenovirus, unspecified formulation"/>
    <definition value="adenovirus vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="24"/>
    <display
             value="Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis"/>
    <definition
                value="Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis"/>
  </concept>
  <concept>
    <code value="19"/>
    <display value="BCG"/>
    <definition value="Bacillus Calmette-Guerin vaccine"/>
  </concept>
  <concept>
    <code value="27"/>
    <display value="botulinum antitoxin"/>
  </concept>
  <concept>
    <code value="26"/>
    <display value="cholera, unspecified formulation"/>
    <definition value="cholera vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="29"/>
    <display value="CMVIG"/>
    <definition value="cytomegalovirus immune globulin, intravenous"/>
  </concept>
  <concept>
    <code value="56"/>
    <display value="dengue fever tetravalent"/>
    <definition value="dengue fever vaccine, tetravalent"/>
  </concept>
  <concept>
    <code value="12"/>
    <display value="diphtheria antitoxin"/>
  </concept>
  <concept>
    <code value="28"/>
    <display value="DT (pediatric)"/>
    <definition
                value="diphtheria and tetanus toxoids, adsorbed for pediatric use"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="20"/>
    <display value="DTaP"/>
    <definition
                value="diphtheria, tetanus toxoids and acellular pertussis vaccine"/>
  </concept>
  <concept>
    <code value="106"/>
    <display value="DTaP, 5 pertussis antigens"/>
    <definition
                value="diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens"/>
  </concept>
  <concept>
    <code value="107"/>
    <display value="DTaP, unspecified formulation"/>
    <definition
                value="diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="110"/>
    <display value="DTaP-Hep B-IPV"/>
    <definition value="DTaP-hepatitis B and poliovirus vaccine"/>
  </concept>
  <concept>
    <code value="50"/>
    <display value="DTaP-Hib"/>
    <definition value="DTaP-Haemophilus influenzae type b conjugate vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="120"/>
    <display value="DTaP-Hib-IPV"/>
    <definition
                value="diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"/>
  </concept>
  <concept>
    <code value="130"/>
    <display value="DTaP-IPV"/>
    <definition
                value="Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated"/>
  </concept>
  <concept>
    <code value="01"/>
    <display value="DTP"/>
    <definition value="diphtheria, tetanus toxoids and pertussis vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="22"/>
    <display value="DTP-Hib"/>
    <definition value="DTP-Haemophilus influenzae type b conjugate vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="102"/>
    <display value="DTP-Hib-Hep B"/>
    <definition
                value="DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine"/>
  </concept>
  <concept>
    <code value="57"/>
    <display value="hantavirus"/>
    <definition value="hantavirus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="52"/>
    <display value="Hep A, adult"/>
    <definition value="hepatitis A vaccine, adult dosage"/>
  </concept>
  <concept>
    <code value="83"/>
    <display value="Hep A, ped/adol, 2 dose"/>
    <definition
                value="hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule"/>
  </concept>
  <concept>
    <code value="84"/>
    <display value="Hep A, ped/adol, 3 dose"/>
    <definition
                value="hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="31"/>
    <display value="Hep A, pediatric, unspecified formulation"/>
    <definition
                value="hepatitis A vaccine, pediatric dosage, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="85"/>
    <display value="Hep A, unspecified formulation"/>
    <definition value="hepatitis A vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="104"/>
    <display value="Hep A-Hep B"/>
    <definition value="hepatitis A and hepatitis B vaccine"/>
  </concept>
  <concept>
    <code value="30"/>
    <display value="HBIG"/>
    <definition value="hepatitis B immune globulin"/>
  </concept>
  <concept>
    <code value="08"/>
    <display value="Hep B, adolescent or pediatric"/>
    <definition
                value="hepatitis B vaccine, pediatric or pediatric/adolescent dosage"/>
  </concept>
  <concept>
    <code value="42"/>
    <display value="Hep B, adolescent/high risk infant"/>
    <definition
                value="hepatitis B vaccine, adolescent/high risk infant dosage"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="43"/>
    <display value="Hep B, adult"/>
    <definition value="hepatitis B vaccine, adult dosage"/>
  </concept>
  <concept>
    <code value="44"/>
    <display value="Hep B, high-dosage, dialysis or IC"/>
    <definition
                value="Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient"/>
  </concept>
  <concept>
    <code value="45"/>
    <display value="Hep B, unspecified formulation"/>
    <definition value="hepatitis B vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="58"/>
    <display value="Hep C"/>
    <definition value="hepatitis C vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="59"/>
    <display value="Hep E"/>
    <definition value="hepatitis E vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="60"/>
    <display value="herpes simplex 2"/>
    <definition value="herpes simplex virus, type 2 vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="46"/>
    <display value="Hib (PRP-D)"/>
    <definition
                value="Haemophilus influenzae type b vaccine, PRP-D conjugate"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="47"/>
    <display value="Hib (HbOC)"/>
    <definition
                value="Haemophilus influenzae type b vaccine, HbOC conjugate"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="48"/>
    <display value="Hib (PRP-T)"/>
    <definition
                value="Haemophilus influenzae type b vaccine, PRP-T conjugate"/>
  </concept>
  <concept>
    <code value="49"/>
    <display value="Hib (PRP-OMP)"/>
    <definition
                value="Haemophilus influenzae type b vaccine, PRP-OMP conjugate"/>
  </concept>
  <concept>
    <code value="17"/>
    <display value="Hib, unspecified formulation"/>
    <definition
                value="Haemophilus influenzae type b vaccine, conjugate unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="51"/>
    <display value="Hib-Hep B"/>
    <definition
                value="Haemophilus influenzae type b conjugate and Hepatitis B vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="61"/>
    <display value="HIV"/>
    <definition value="human immunodeficiency virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="118"/>
    <display value="HPV, bivalent"/>
    <definition value="human papilloma virus vaccine, bivalent"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="62"/>
    <display value="HPV, quadrivalent"/>
    <definition value="human papilloma virus vaccine, quadrivalent"/>
  </concept>
  <concept>
    <code value="86"/>
    <display value="IG"/>
    <definition value="immune globulin, intramuscular"/>
  </concept>
  <concept>
    <code value="87"/>
    <display value="IGIV"/>
    <definition value="immune globulin, intravenous"/>
  </concept>
  <concept>
    <code value="14"/>
    <display value="IG, unspecified formulation"/>
    <definition value="immune globulin, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="111"/>
    <display value="Influenza, live, trivalent, intranasal, PF"/>
    <definition
                value="Influenza, live, trivalent, intranasal, preservative free"/>
  </concept>
  <concept>
    <code value="15"/>
    <display value="influenza, split (incl. purified surface antigen)"/>
    <definition
                value="influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="16"/>
    <display value="influenza, whole"/>
    <definition value="influenza virus vaccine, whole virus"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="88"/>
    <display value="influenza, unspecified formulation"/>
    <definition value="influenza virus vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="123"/>
    <display value="influenza, H5N1-1203"/>
    <definition
                value="influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="10"/>
    <display value="IPV"/>
    <definition value="poliovirus vaccine, inactivated"/>
  </concept>
  <concept>
    <code value="02"/>
    <display value="OPV, trivalent"/>
    <definition value="trivalent poliovirus vaccine, live, oral"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="89"/>
    <display value="polio, unspecified formulation"/>
    <definition value="poliovirus vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="39"/>
    <display value="Japanese encephalitis SC"/>
    <definition value="Japanese Encephalitis Vaccine SC"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="63"/>
    <display value="Junin virus"/>
    <definition value="Junin virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="64"/>
    <display value="leishmaniasis"/>
    <definition value="leishmaniasis vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="65"/>
    <display value="leprosy"/>
    <definition value="leprosy vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="66"/>
    <display value="Lyme disease"/>
    <definition value="Lyme disease vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="03"/>
    <display value="MMR"/>
    <definition value="measles, mumps and rubella virus vaccine"/>
  </concept>
  <concept>
    <code value="04"/>
    <display value="M/R"/>
    <definition value="measles and rubella virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="94"/>
    <display value="MMRV"/>
    <definition value="measles, mumps, rubella, and varicella virus vaccine"/>
  </concept>
  <concept>
    <code value="67"/>
    <display value="malaria"/>
    <definition value="malaria vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="05"/>
    <display value="measles"/>
    <definition value="measles virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="68"/>
    <display value="melanoma"/>
    <definition value="melanoma vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="32"/>
    <display value="meningococcal MPSV4"/>
    <definition value="meningococcal polysaccharide vaccine (MPSV4)"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="103"/>
    <display value="meningococcal C conjugate"/>
    <definition value="meningococcal C conjugate vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="114"/>
    <display value="meningococcal MCV4P"/>
    <definition
                value="meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)"/>
  </concept>
  <concept>
    <code value="108"/>
    <display value="meningococcal ACWY, unspecified formulation"/>
    <definition value="meningococcal ACWY vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="07"/>
    <display value="mumps"/>
    <definition value="mumps virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="69"/>
    <display value="parainfluenza-3"/>
    <definition value="parainfluenza-3 virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="11"/>
    <display value="pertussis"/>
    <definition value="pertussis vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="23"/>
    <display value="plague"/>
    <definition value="plague vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="33"/>
    <display value="pneumococcal polysaccharide PPV23"/>
    <definition value="pneumococcal polysaccharide vaccine, 23 valent"/>
  </concept>
  <concept>
    <code value="100"/>
    <display value="pneumococcal conjugate PCV 7"/>
    <definition value="pneumococcal conjugate vaccine, 7 valent"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="109"/>
    <display value="pneumococcal, unspecified formulation"/>
    <definition value="pneumococcal vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="70"/>
    <display value="Q fever"/>
    <definition value="Q fever vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="18"/>
    <display value="rabies, intramuscular injection"/>
    <definition
                value="rabies vaccine, for intramuscular injection RETIRED CODE"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="40"/>
    <display value="rabies, intradermal injection"/>
    <definition value="rabies vaccine, for intradermal injection"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="90"/>
    <display value="rabies, unspecified formulation"/>
    <definition value="rabies vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="72"/>
    <display value="rheumatic fever"/>
    <definition value="rheumatic fever vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="73"/>
    <display value="Rift Valley fever"/>
    <definition value="Rift Valley fever vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="34"/>
    <display value="RIG"/>
    <definition value="rabies immune globulin"/>
  </concept>
  <concept>
    <code value="119"/>
    <display value="rotavirus, monovalent"/>
    <definition value="rotavirus, live, monovalent vaccine"/>
  </concept>
  <concept>
    <code value="122"/>
    <display value="rotavirus, unspecified formulation"/>
    <definition value="rotavirus vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="116"/>
    <display value="rotavirus, pentavalent"/>
    <definition value="rotavirus, live, pentavalent vaccine"/>
  </concept>
  <concept>
    <code value="74"/>
    <display value="rotavirus, tetravalent"/>
    <definition value="rotavirus, live, tetravalent vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="71"/>
    <display value="RSV-IGIV"/>
    <definition
                value="respiratory syncytial virus immune globulin, intravenous"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="93"/>
    <display value="RSV-MAb"/>
    <definition
                value="respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular"/>
  </concept>
  <concept>
    <code value="06"/>
    <display value="rubella"/>
    <definition value="rubella virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="38"/>
    <display value="rubella/mumps"/>
    <definition value="rubella and mumps virus vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="76"/>
    <display value="Staphylococcus bacterio lysate"/>
    <definition value="Staphylococcus bacteriophage lysate"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="113"/>
    <display
             value="Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"/>
    <definition
                value="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)"/>
  </concept>
  <concept>
    <code value="09"/>
    <display
             value="Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed"/>
    <definition
                value="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)"/>
  </concept>
  <concept>
    <code value="115"/>
    <display value="Tdap"/>
    <definition
                value="tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed"/>
  </concept>
  <concept>
    <code value="35"/>
    <display value="tetanus toxoid, adsorbed"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="112"/>
    <display value="tetanus toxoid, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="77"/>
    <display value="Tick-borne encephalitis vaccine (non-US)"/>
  </concept>
  <concept>
    <code value="13"/>
    <display value="TIG"/>
    <definition value="tetanus immune globulin"/>
  </concept>
  <concept>
    <code value="95"/>
    <display value="TST-OT tine test"/>
    <definition
                value="tuberculin skin test; old tuberculin, multipuncture device"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="96"/>
    <display value="TST-PPD intradermal"/>
    <definition
                value="tuberculin skin test; purified protein derivative solution, intradermal"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="97"/>
    <display value="TST-PPD tine test"/>
    <definition
                value="tuberculin skin test; purified protein derivative, multipuncture device"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="98"/>
    <display value="TST, unspecified formulation"/>
    <definition value="tuberculin skin test; unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="78"/>
    <display value="tularemia vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="91"/>
    <display value="typhoid, unspecified formulation"/>
    <definition value="typhoid vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="25"/>
    <display value="typhoid, oral"/>
    <definition value="typhoid vaccine, live, oral"/>
  </concept>
  <concept>
    <code value="41"/>
    <display value="typhoid, parenteral"/>
    <definition
                value="typhoid vaccine, parenteral, other than acetone-killed, dried"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="53"/>
    <display value="typhoid, parenteral, AKD (U.S. military)"/>
    <definition
                value="typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="101"/>
    <display value="typhoid, ViCPs"/>
    <definition value="typhoid Vi capsular polysaccharide vaccine"/>
  </concept>
  <concept>
    <code value="75"/>
    <display value="Vaccinia (smallpox, monkeypox), live"/>
    <definition value="Vaccinia (smallpox, monkeypox) vaccine, live"/>
  </concept>
  <concept>
    <code value="105"/>
    <display value="vaccinia (smallpox) diluted"/>
    <definition value="vaccinia (smallpox) vaccine, diluted"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="79"/>
    <display value="vaccinia immune globulin"/>
  </concept>
  <concept>
    <code value="21"/>
    <display value="varicella"/>
    <definition value="varicella virus vaccine"/>
  </concept>
  <concept>
    <code value="81"/>
    <display value="VEE, inactivated"/>
    <definition value="Venezuelan equine encephalitis, inactivated"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="80"/>
    <display value="VEE, live"/>
    <definition value="Venezuelan equine encephalitis, live, attenuated"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="92"/>
    <display value="VEE, unspecified formulation"/>
    <definition
                value="Venezuelan equine encephalitis vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="36"/>
    <display value="VZIG"/>
    <definition value="varicella zoster immune globulin"/>
  </concept>
  <concept>
    <code value="117"/>
    <display value="VZIG (IND)"/>
    <definition
                value="varicella zoster immune globulin (Investigational New Drug)"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="37"/>
    <display value="yellow fever live"/>
    <definition value="yellow fever vaccine live"/>
  </concept>
  <concept>
    <code value="121"/>
    <display value="zoster live"/>
    <definition value="zoster vaccine, live"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="998"/>
    <display value="no vaccine administered"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="999"/>
    <display value="unknown"/>
    <definition value="unknown vaccine or immune globulin"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="99"/>
    <display value="RESERVED - do not use"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="133"/>
    <display value="Pneumococcal conjugate PCV 13"/>
    <definition value="pneumococcal conjugate vaccine, 13 valent"/>
  </concept>
  <concept>
    <code value="134"/>
    <display value="Japanese Encephalitis IM"/>
    <definition
                value="Japanese Encephalitis vaccine for intramuscular administration"/>
  </concept>
  <concept>
    <code value="137"/>
    <display value="HPV, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="136"/>
    <display value="Meningococcal MCV4O"/>
    <definition
                value="meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)"/>
  </concept>
  <concept>
    <code value="135"/>
    <display value="Influenza, high-dose, trivalent, PF"/>
    <definition
                value="Influenza, high-dose, split virus, trivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="131"/>
    <display value="typhus, historical"/>
    <definition value="Historical record of a typhus vaccination"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="132"/>
    <display value="DTaP-IPV-HIB-HEP B, historical"/>
    <definition
                value="Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine."/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="128"/>
    <display value="Novel Influenza-H1N1-09, all formulations"/>
    <definition value="Novel influenza-H1N1-09, all formulations"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="125"/>
    <display value="Novel Influenza-H1N1-09, nasal"/>
    <definition
                value="Novel Influenza-H1N1-09, live virus for nasal administration"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="126"/>
    <display value="Novel influenza-H1N1-09, preservative-free"/>
    <definition
                value="Novel influenza-H1N1-09, preservative-free, injectable"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="127"/>
    <display value="Novel influenza-H1N1-09"/>
    <definition value="Novel influenza-H1N1-09, injectable"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="138"/>
    <display value="Td (adult)"/>
    <definition
                value="tetanus and diphtheria toxoids, not adsorbed, for adult use"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="139"/>
    <display value="Td(adult) unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="140"/>
    <display value="Influenza, split virus, trivalent, PF"/>
    <definition
                value="Influenza, split virus, trivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="129"/>
    <display value="Japanese Encephalitis, unspecified formulation"/>
    <definition
                value="Japanese Encephalitis vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="141"/>
    <display value="Influenza, split virus, trivalent, preservative"/>
    <definition
                value="Influenza, split virus, trivalent, injectable, contains preservative"/>
  </concept>
  <concept>
    <code value="142"/>
    <display value="tetanus toxoid, not adsorbed"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="143"/>
    <display value="Adenovirus types 4 and 7"/>
    <definition value="Adenovirus, type 4 and type 7, live, oral"/>
  </concept>
  <concept>
    <code value="144"/>
    <display value="influenza, seasonal, intradermal, preservative free"/>
    <definition value="seasonal influenza, intradermal, preservative free"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="145"/>
    <display value="RSV-MAb (new)"/>
    <definition
                value="respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="146"/>
    <display value="DTaP,IPV,Hib,HepB"/>
    <definition
                value="Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine."/>
  </concept>
  <concept>
    <code value="147"/>
    <display value="meningococcal MCV4, unspecified formulation"/>
    <definition
                value="Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="148"/>
    <display value="Meningococcal C/Y-HIB PRP"/>
    <definition
                value="Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="149"/>
    <display value="Influenza, live, quadrivalent, intranasal"/>
  </concept>
  <concept>
    <code value="150"/>
    <display value="Influenza, split virus, quadrivalent, PF"/>
    <definition
                value="Influenza, split virus, quadrivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="151"/>
    <display value="influenza nasal, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="152"/>
    <display value="Pneumococcal Conjugate, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="153"/>
    <display value="Influenza, MDCK, trivalent, PF"/>
    <definition
                value="Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="154"/>
    <display value="Hep A, IG"/>
    <definition value="Hepatitis A immune globulin"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="155"/>
    <display value="Influenza, recombinant, trivalent, PF"/>
    <definition
                value="Influenza, recombinant, trivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="156"/>
    <display value="Rho(D)-IG"/>
    <definition value="Rho(D) Immune globulin- IV or IM"/>
  </concept>
  <concept>
    <code value="157"/>
    <display value="Rho(D) -IG IM"/>
    <definition value="Rho(D) Immune globulin - IM"/>
  </concept>
  <concept>
    <code value="158"/>
    <display value="Influenza, split virus, quadrivalent, preservative"/>
    <definition
                value="Influenza, split virus, quadrivalent, injectable, contains preservative"/>
  </concept>
  <concept>
    <code value="159"/>
    <display value="Rho(D) - Unspecified formulation"/>
    <definition value="Rho(D) Unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="160"/>
    <display value="Influenza A monovalent (H5N1), ADJUVANTED-2013"/>
    <definition
                value="Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013"/>
  </concept>
  <concept>
    <code value="801"/>
    <display value="AS03 Adjuvant"/>
  </concept>
  <concept>
    <code value="161"/>
    <display
             value="Influenza, injectable,quadrivalent, preservative free, pediatric"/>
  </concept>
  <concept>
    <code value="162"/>
    <display value="meningococcal B, recombinant"/>
    <definition value="meningococcal B vaccine, fully recombinant"/>
  </concept>
  <concept>
    <code value="163"/>
    <display value="meningococcal B, OMV"/>
    <definition
                value="meningococcal B vaccine, recombinant, OMV, adjuvanted"/>
  </concept>
  <concept>
    <code value="164"/>
    <display value="meningococcal B, unspecified"/>
    <definition value="meningococcal B, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="165"/>
    <display value="HPV9"/>
    <definition value="Human Papillomavirus 9-valent vaccine"/>
  </concept>
  <concept>
    <code value="166"/>
    <display value="influenza, intradermal, quadrivalent, preservative free"/>
    <definition
                value="influenza, intradermal, quadrivalent, preservative free, injectable"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="167"/>
    <display value="meningococcal, unknown serogroups"/>
    <definition
                value="meningococcal vaccine of unknown formulation and unknown serogroups"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="168"/>
    <display value="Influenza, adjuvanted, trivalent, PF"/>
    <definition
                value="Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="169"/>
    <display value="Hep A, live attenuated"/>
    <definition value="Hep A, live attenuated-IM"/>
  </concept>
  <concept>
    <code value="170"/>
    <display value="DTAP/IPV/HIB - non-US"/>
    <definition
                value="non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"/>
  </concept>
  <concept>
    <code value="171"/>
    <display value="Influenza, MDCK, quadrivalent, PF"/>
    <definition
                value="Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="172"/>
    <display value="cholera, WC-rBS"/>
  </concept>
  <concept>
    <code value="173"/>
    <display value="cholera, BivWC"/>
  </concept>
  <concept>
    <code value="174"/>
    <display value="cholera, live attenuated"/>
  </concept>
  <concept>
    <code value="175"/>
    <display value="Rabies - IM Diploid cell culture"/>
    <definition value="Human Rabies vaccine from human diploid cell culture"/>
  </concept>
  <concept>
    <code value="176"/>
    <display value="Rabies - IM fibroblast culture"/>
    <definition value="Human rabies vaccine from Chicken fibroblast culture"/>
  </concept>
  <concept>
    <code value="177"/>
    <display value="PCV10"/>
    <definition value="pneumococcal conjugate vaccine, 10 valent"/>
  </concept>
  <concept>
    <code value="178"/>
    <display value="OPV bivalent"/>
    <definition value="Non-US bivalent oral polio vaccine (types 1 and 3)"/>
  </concept>
  <concept>
    <code value="179"/>
    <display value="OPV ,monovalent, unspecified"/>
    <definition
                value="Non-US monovalent oral polio vaccine, unspecified formulation"/>
  </concept>
  <concept>
    <code value="180"/>
    <display value="tetanus immune globulin"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="181"/>
    <display value="anthrax immune globulin"/>
  </concept>
  <concept>
    <code value="182"/>
    <display value="OPV, Unspecified"/>
    <definition value="Oral Polio Vaccine, Unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="183"/>
    <display value="Yellow fever vaccine live - alt"/>
    <definition
                value="Yellow fever vaccine live - alternative formulation for vaccine shortage"/>
  </concept>
  <concept>
    <code value="184"/>
    <display value="Yellow fever, unspecified"/>
    <definition value="Yellow fever vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="185"/>
    <display value="Influenza, recombinant, quadrivalent, PF"/>
    <definition
                value="Influenza, recombinant, quadrivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="186"/>
    <display value="Influenza, MDCK, quadrivalent, preservative"/>
    <definition
                value="Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative"/>
  </concept>
  <concept>
    <code value="187"/>
    <display value="zoster recombinant"/>
    <definition value="zoster vaccine recombinant"/>
  </concept>
  <concept>
    <code value="188"/>
    <display value="zoster, unspecified formulation"/>
    <definition value="zoster vaccine, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="189"/>
    <display value="HepB-CpG"/>
    <definition value="Hepatitis B vaccine (recombinant), CpG adjuvanted"/>
  </concept>
  <concept>
    <code value="190"/>
    <display value="Typhoid conjugate vaccine (TCV)"/>
    <definition value="Typhoid conjugate vaccine (non-US)"/>
  </concept>
  <concept>
    <code value="191"/>
    <display value="meningococcal A polysaccharide (non-US)"/>
    <definition value="meningococcal A polysaccharide vaccine (non-US)"/>
  </concept>
  <concept>
    <code value="192"/>
    <display value="meningococcal AC polysaccharide (non-US)"/>
    <definition value="meningococcal AC polysaccharide vaccine (non-US)"/>
  </concept>
  <concept>
    <code value="193"/>
    <display value="Hep A-Hep B, pediatric/adolescent"/>
    <definition
                value="hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)"/>
  </concept>
  <concept>
    <code value="194"/>
    <display value="Influenza, Southern Hemisphere"/>
    <definition
                value="influenza, Southern Hemisphere, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="195"/>
    <display value="DT, IPV adsorbed"/>
    <definition value="Diphtheria, Tetanus, Poliomyelitis adsorbed"/>
  </concept>
  <concept>
    <code value="196"/>
    <display
             value="Td, adsorbed, preservative free, adult use, Lf unspecified"/>
    <definition
                value="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified"/>
  </concept>
  <concept>
    <code value="197"/>
    <display value="Influenza, high-dose, quadrivalent, PF"/>
    <definition
                value="Influenza, high-dose, split virus, quadrivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="200"/>
    <display
             value="influenza, Southern Hemisphere, pediatric, preservative free"/>
    <definition
                value="influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free"/>
  </concept>
  <concept>
    <code value="201"/>
    <display value="Influenza, Southern Hemisphere, quadrivalent, PF"/>
    <definition
                value="Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free"/>
  </concept>
  <concept>
    <code value="202"/>
    <display
             value="influenza, Southern Hemisphere, quadrivalent, with preservative"/>
    <definition
                value="influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative"/>
  </concept>
  <concept>
    <code value="198"/>
    <display value="DTP-hepB-Hib Pentavalent Non-US"/>
    <definition
                value="Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)"/>
  </concept>
  <concept>
    <code value="203"/>
    <display value="meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)"/>
    <definition
                value="meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free"/>
  </concept>
  <concept>
    <code value="205"/>
    <display value="Influenza, adjuvanted, quadrivalent, PF"/>
    <definition
                value="Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="206"/>
    <display
             value="Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection"/>
    <definition
                value="Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection"/>
  </concept>
  <concept>
    <code value="207"/>
    <display
             value="COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="208"/>
    <display value="COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="213"/>
    <display value="SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="210"/>
    <display value="COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL"/>
  </concept>
  <concept>
    <code value="212"/>
    <display value="COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="204"/>
    <display value="Ebola Zaire vaccine, live, recombinant, 1mL dose"/>
  </concept>
  <concept>
    <code value="214"/>
    <display value="Ebola, unspecified"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="211"/>
    <display
             value="COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="500"/>
    <display value="COVID-19 Non-US Vaccine, UNSPECIFIED"/>
    <definition value="SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED"/>
  </concept>
  <concept>
    <code value="501"/>
    <display value="COVID-19 IV Non-US Vaccine (QAZCOVID-IN)"/>
    <definition
                value="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)"/>
  </concept>
  <concept>
    <code value="502"/>
    <display value="COVID-19 IV Non-US Vaccine (COVAXIN)"/>
    <definition
                value="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)"/>
  </concept>
  <concept>
    <code value="503"/>
    <display value="COVID-19 LAV Non-US Vaccine (COVIVAC)"/>
    <definition
                value="SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)"/>
  </concept>
  <concept>
    <code value="504"/>
    <display value="COVID-19 VVnr Non-US Vaccine (Sputnik Light)"/>
    <definition
                value="SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)"/>
  </concept>
  <concept>
    <code value="505"/>
    <display value="COVID-19 VVnr Non-US Vaccine (Sputnik V)"/>
    <definition
                value="SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)"/>
  </concept>
  <concept>
    <code value="506"/>
    <display
             value="COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology"/>
    <definition
                value="SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology"/>
  </concept>
  <concept>
    <code value="507"/>
    <display
             value="COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)"/>
    <definition
                value="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)"/>
  </concept>
  <concept>
    <code value="508"/>
    <display
             value="COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)"/>
    <definition
                value="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)"/>
  </concept>
  <concept>
    <code value="509"/>
    <display value="COVID-19 PS Non-US Vaccine (EpiVacCorona)"/>
    <definition
                value="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)"/>
  </concept>
  <concept>
    <code value="510"/>
    <display value="COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)"/>
    <definition
                value="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)"/>
  </concept>
  <concept>
    <code value="511"/>
    <display value="COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)"/>
    <definition
                value="SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)"/>
  </concept>
  <concept>
    <code value="215"/>
    <display
             value="Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF"/>
    <definition
                value="Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free"/>
  </concept>
  <concept>
    <code value="216"/>
    <display
             value="Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"/>
    <definition
                value="Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free"/>
  </concept>
  <concept>
    <code value="219"/>
    <display
             value="COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="217"/>
    <display
             value="COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="218"/>
    <display
             value="COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="220"/>
    <display value="HepB recombinant, 3-antigen, Al(OH)3"/>
    <definition
                value="Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="221"/>
    <display value="COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="222"/>
    <display value="Tick-borne encephalitis, unspecified"/>
    <definition value="Tick-borne encephalitis vaccine, unspecified"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="223"/>
    <display value="Tick-borne encephalitis, inactivated, PF, 0.25mL"/>
    <definition
                value="Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose"/>
  </concept>
  <concept>
    <code value="224"/>
    <display value="Tick-borne encephalitis, inactivated, PF, 0.5mL"/>
    <definition
                value="Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose"/>
  </concept>
  <concept>
    <code value="225"/>
    <display
             value="COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="226"/>
    <display
             value="COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="512"/>
    <display
             value="SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)"/>
    <definition
                value="SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)"/>
  </concept>
  <concept>
    <code value="513"/>
    <display
             value="SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)"/>
    <definition
                value="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)"/>
  </concept>
  <concept>
    <code value="514"/>
    <display
             value="SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)"/>
    <definition
                value="SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)"/>
  </concept>
  <concept>
    <code value="515"/>
    <display
             value="SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)"/>
    <definition
                value="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)"/>
  </concept>
  <concept>
    <code value="516"/>
    <display
             value="COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"/>
    <definition
                value="SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"/>
  </concept>
  <concept>
    <code value="517"/>
    <display
             value="SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)"/>
    <definition
                value="SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)"/>
  </concept>
  <concept>
    <code value="227"/>
    <display value="COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="228"/>
    <display
             value="COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="229"/>
    <display
             value="COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="301"/>
    <display value="COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="300"/>
    <display value="COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="230"/>
    <display value="COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="518"/>
    <display value="COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"/>
    <definition
                value="SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"/>
  </concept>
  <concept>
    <code value="519"/>
    <display
             value="COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"/>
    <definition
                value="SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"/>
  </concept>
  <concept>
    <code value="520"/>
    <display
             value="COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech"/>
    <definition
                value="SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech"/>
  </concept>
  <concept>
    <code value="521"/>
    <display
             value="COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK"/>
  </concept>
  <concept>
    <code value="231"/>
    <display value="influenza, Southern Hemisphere, high-dose, quadrivalent"/>
    <definition
                value="influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free"/>
  </concept>
  <concept>
    <code value="303"/>
    <display
             value="RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF"/>
    <definition
                value="Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free"/>
  </concept>
  <concept>
    <code value="304"/>
    <display value="Respiratory syncytial virus (RSV), unspecified"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="305"/>
    <display
             value="RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF"/>
    <definition
                value="Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free"/>
  </concept>
  <concept>
    <code value="306"/>
    <display value="RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months"/>
    <definition
                value="Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months"/>
  </concept>
  <concept>
    <code value="307"/>
    <display value="RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months"/>
    <definition
                value="Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months"/>
  </concept>
  <concept>
    <code value="313"/>
    <display
             value="COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose"/>
  </concept>
  <concept>
    <code value="308"/>
    <display value="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="309"/>
    <display value="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose"/>
  </concept>
  <concept>
    <code value="310"/>
    <display value="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose"/>
  </concept>
  <concept>
    <code value="312"/>
    <display value="COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose"/>
  </concept>
  <concept>
    <code value="311"/>
    <display value="COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose"/>
  </concept>
  <concept>
    <code value="315"/>
    <display value="Respiratory syncytial virus (RSV) MAB, unspecified"/>
    <definition
                value="Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="314"/>
    <display value="Respiratory syncytial virus (RSV) vaccine, unspecified"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="316"/>
    <display
             value="Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF"/>
    <definition
                value="Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free"/>
  </concept>
  <concept>
    <code value="317"/>
    <display value="Chikungunya live attenuated vaccine, 0.5 mL, PF"/>
    <definition
                value="Chikungunya, live attenuated vaccine, 0.5 mL, preservative free"/>
  </concept>
  <concept>
    <code value="318"/>
    <display value="Anthrax, post-exposure prophylaxis"/>
    <definition
                value="Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis"/>
  </concept>
  <concept>
    <code value="319"/>
    <display value="Anthrax vaccine, unspecified"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="320"/>
    <display value="Influenza, MDCK, trivalent, preservative"/>
    <definition
                value="Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative"/>
  </concept>
  <concept>
    <code value="321"/>
    <display value="Influenza-avian, H5N8, monovalent, PF"/>
    <definition
                value="Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="322"/>
    <display value="Influenza-avian, H5N8, monovalent, preservative"/>
    <definition
                value="Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative"/>
  </concept>
  <concept>
    <code value="324"/>
    <display value="Poliovirus, inactivated, fractional-dose (fIPV)"/>
  </concept>
  <concept>
    <code value="323"/>
    <display value="Influenza-avian, H5, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="326"/>
    <display value="RSV, mRNA, injectable, PF"/>
    <definition
                value="Respiratory syncytial virus (RSV), mRNA, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="327"/>
    <display
             value="Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF"/>
    <definition
                value="Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free"/>
  </concept>
  <concept>
    <code value="328"/>
    <display value="Meningococcal oligosaccharide (MenACWY), (MenB), PF"/>
    <definition
                value="Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free"/>
  </concept>
  <concept>
    <code value="329"/>
    <display value="Chikungunya, VLP, recombinant, 0.8 mL, PF"/>
    <definition
                value="Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free"/>
  </concept>
  <concept>
    <code value="330"/>
    <display value="Dengue fever, unspecified"/>
    <definition value="Dengue fever, unspecified formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="331"/>
    <display value="Influenza, Southern Hemisphere, trivalent, PF"/>
    <definition
                value="Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free"/>
  </concept>
  <concept>
    <code value="325"/>
    <display value="Vaccinia (smallpox, monkeypox), unspecified"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
  <concept>
    <code value="332"/>
    <display
             value="RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF"/>
    <definition
                value="Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free"/>
  </concept>
  <concept>
    <code value="333"/>
    <display
             value="Influenza, live, trivalent, intranasal, self/caregiver admin, PF"/>
    <definition
                value="Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free"/>
  </concept>
  <concept>
    <code value="334"/>
    <display value="COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose"/>
  </concept>
  <concept>
    <code value="337"/>
    <display
             value="Influenza, Southern Hemisphere, high-dose, trivalent, PF"/>
    <definition
                value="Influenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free"/>
  </concept>
  <concept>
    <code value="302"/>
    <display value="COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose"/>
    <definition
                value="SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation"/>
    <property>
      <code value="status"/>
      <valueCode value="retired"/>
    </property>
  </concept>
</CodeSystem>